Cargando…
Is plasma caveolin-1 level a prognostic biomarker in metastatic pancreatic cancer?
BACKGROUND/AIMS: To evaluate the prognostic significance of plasma caveolin (CAV)-1 and its association with survival and treatment response rates in metastatic pancreatic cancer (MPC). PATIENTS AND METHODS: Plasma samples were prospectively collected from 41 patients with newly diagnosed MPC. Moreo...
Autores principales: | Demirci, Nebi S., Dogan, Mutlu, Erdem, Gokmen U., Kacar, Sabite, Turhan, Turan, Kilickap, Saadettin, Cigirgan, Lutfi C., Kayacetin, Ertugrul, Bozkaya, Yakup, Zengin, Nurullah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470378/ https://www.ncbi.nlm.nih.gov/pubmed/28611342 http://dx.doi.org/10.4103/sjg.SJG_483_16 |
Ejemplares similares
-
A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer
por: Bozkaya, Yakup, et al.
Publicado: (2018) -
The Relationship Between Platelet–Lymphocyte Ratio, Neutrophil–Lymphocyte Ratio, and Survival in Metastatic Gastric Cancer on Firstline Modified Docetaxel and Cisplatinum Plus 5 Fluorourasil Regimen: A Single Institute Experience
por: Dogan, Mutlu, et al.
Publicado: (2015) -
Is the serum level of survivin, an antiapoptotic protein, a potential predictive and prognostic biomarker in metastatic pancreatic cancer?
por: Demirci, Nebi Serkan, et al.
Publicado: (2023) -
Reproductive cancer risk factors among relatives of cancer patients in a tertiary oncology center
por: Atta, Nooria, et al.
Publicado: (2019) -
Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab
por: Menteşoğlu, Dilek, et al.
Publicado: (2022)